Please login to the form below

Not currently logged in
Email:
Password:

sembragiline

This page shows the latest sembragiline news and features for those working in and with pharma, biotech and healthcare.

EMA unveils draft guidelines for Alzheimer’s disease research

EMA unveils draft guidelines for Alzheimer’s disease research

Last year Roche and Evotec's sembragiline failed a phase II trial and Pfizer this week announced it has halted development of its candidate, PF-05212377, after it too failed to

Latest news

  • Roche and Evotec’s Alzheimer’s drug ineffective Roche and Evotec’s Alzheimer’s drug ineffective

    Sembragiline failed to show cognitive and memory benefits. The quest for an effective therapy for Alzheimer's disease seems to have claimed another casualty, with a drug developed by Evotec and ... Roche reports that sembragiline – a drug in the

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

DNA
Why precision medicine demands precision engagement
The speed of innovation brings its own challenges, says cloud computing expert...
Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...

Infographics